Case Studies
Real numbers. Real outcomes.
A cross-section of engagements showing what happens when established businesses formally recognize and capitalize their data assets. All figures are actual results. Clients anonymized.
7
Published case studies across healthcare, technology, aerospace, retail, and arts sectors.
Pre and post-valuation figures shown. Currency reflects jurisdiction of engagement.
Case Study A · MedTech AI
From £5M to £94.7M - and growing.
Predictive AI platform leverages data valuation for investment and exit negotiations.
£5M
Pre-Valuation
- Series A company
- 13.7M data records
- AI-driven predictive algorithms
- Value unrecognized on balance sheet
£94.7M
Post-Valuation (Rebalance 2)
- Initial post-valuation: £59M
- Rebalanced to £74.9M at 6 months as more data was generated
- Rebalanced again to £94.7M at 12 months
- Received investment offers of £6M and £20M off the back of the data asset
- Repricing strategy developed for algorithms to pharma partners
The outcome
Data valuation rebalanced twice as new data was generated - demonstrating that recognized data assets grow in value over time, not just at point of first recognition.
Case Study B · Medical Research
From £5M to £47M - plus a new £10.2M business line.
Cancer research platform discovers hidden asset value and an entirely new revenue stream.
£5M
Pre-Valuation
- Series B company
- ~60M data records
- Clinical and non-clinical data across multiple sources
- Unique imaging data - value unquantified
£47M
Post-Valuation
- Full data ecosystem recognized as intangible asset
- Imaging data identified as a separate business line worth up to £10.2M
- Calculated price of a distinct cancer model for potential sale or acquisition
- Data ROI calculated by business line
- Data licensing strategy developed
The outcome
The valuation didn't just recognize existing value - it uncovered a new revenue stream the client hadn't considered. The imaging data alone represented a £10.2M business line.
Case Study C · Medical - MSK Platform
From £2M to £34M - exit strategy enabled.
Healthcare triage platform uses data valuation to unlock corporate wellness exit at premium multiples.
£2M
Pre-Valuation
- Series A company
- 85.5M data permutations
- 10,000 patient records
- White-label platform with affiliated business channels
£34M
Post-Valuation
- Medical pathways recognized as individual data assets
- Data value broken down by client, pathway, and patient type
- Exit strategy to corporate wellness clients unlocked
- Platform and data identified as separately sellable assets
The outcome
A 17x uplift in recognized value. The engagement also identified that the platform and its underlying data could be sold to separate buyers - doubling the exit optionality.
Case Study D · Aerospace, Engineering & Construction
From $1M to $66.8M - data lending unlocked.
Analytics platform serving capital project markets leverages data for funding and balance sheet recognition.
$1M
Pre-Valuation
- Series A company
- 7,108 entities tracked
- 26M+ data records
- Over $190B in accessible public capital projects in dataset
$66.8M
Post-Valuation
- Full dataset recognized as defensible intangible asset
- $1M data lending facility released immediately
- 20% equity buy-in option structured for strategic investor
- Data value broken down by sector for pricing validation
The outcome
A 66x uplift from $1M to $66.8M. The valuation unlocked immediate data-backed lending and created a structured pathway for a strategic investor buy-in.
Case Study E · Medical - Patient Data
From £15M to £852M - £60M investment offer received.
Patient data platform secures major investment offer after data valuation reframes the asset entirely.
£15M
Pre-Valuation
- Series A company
- 400,000 patient records
- 38.7M medication records
- Asset strategy based on technology - data value unrecognized
£852M
Post-Valuation
- Full data ecosystem recognized as balance sheet asset
- Received £60M investment offer following provision of the valuation
- Also received 20% equity buyout option
- Repricing strategy developed for data use cases
- Funding strategy secured against data asset value
The outcome
A 56x uplift. The valuation reframed the business from a technology company to a data asset company - and investors responded immediately with a £60M offer.
Case Study H · Art & Creative Assets
From zero recognized value to $89.9M.
Artist and sculptor discovers provenance data has never been formally valued - and unlocks asset-backed lending.
$0
Pre-Valuation
- Active artist and sculptor
- 4,450+ pieces of artwork
- 10,000+ provenance data points
- Provenance value had never been formally calculated
$89.9M
Post-Valuation
- Provenance data formally recognized as intangible asset
- Data asset backed lending unlocked
- Subscription model for provenance data identified
- Replacement value established for insurance and estate purposes
The outcome
The value was always there - in notes, journals, images, contracts, and digitized records. It had simply never been formally recognized. One engagement changed that entirely.
Case Study I · Design & Merchandise
From $40M to $3.94B - even after dissolution.
Dissolved retail merchandiser discovers data assets survive the company - and can fund re-activation or sale.
$40M
Pre-Valuation
- Former industry-leading retail apparel merchandiser
- Served 1,000+ global entertainment and retail clients
- Company dissolved - but data assets remained
- 2.7B data points across branding, merchandising, social media, and CRM
$3.94B
Post-Valuation
- Full data ecosystem recognized at $3.94B
- CRM client lifetime value uplift of $25M
- Data asset backed lending enabled for sale or company re-activation
- CRM data added to balance sheet as distinct intangible asset
The outcome
The company dissolved. The data didn't. A 98x uplift demonstrated that data assets outlive the business structures that generated them - and can fund entirely new chapters.
Want to see what your numbers could look like?
Every engagement starts with a free 48-hour snapshot. No raw data required.
Get your free snapshot